Is Structure Therapeutics Inc. (GPCR) a Buy, Sell, or Hold?
NASDAQ : GPCR
Structure Therapeutics Inc. — Analyst Ratings
$48.04 USD
-$1.43 (-2.89%)
- Volume
- 407.59K
- Average Volume
- 758.41K
- Market Capitalization
- $2.77B
- P/E Ratio
- -18.20
- Dividend Yield
- 0.00%
- Price Target
- $101.00
- Year High
- $94.90
- Year Low
- $15.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $26.16
Analyst Consensus Summary
Consensus Rating
Sell
14 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-52.4%
vs Current Price
Price Target
$101.00
Average TargetPrice Target Range
Lowest Target
$70.00
-31.4% DOWNSIDE
Average Target
$101.00
Median Estimate
Highest Target
$145.00
-66.9% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 14
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 14 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Ananda Ghosh | $70 | $41.53 | 2026-06-11 06:42 AM | 68.6% |
| BMO Capital | Evan Seigerman | $145 | $56.8846 | 2026-03-17 08:29 AM | 154.9% |
| H.C. Wainwright | Ananda Ghosh | $90 | $66.45 | 2025-12-19 08:43 AM | 35.4% |
| Morgan Stanley | Terence Flynn | $125 | $66.235 | 2025-12-12 08:10 AM | 88.7% |
| Stifel Nicolaus | Annabel Samimy | $50 | $33.89 | 2025-12-02 09:21 AM | 47.5% |